Edition:
United States

Insider Trading: Merck & Co Inc (MRK.N)

MRK.N on New York Stock Exchange

62.33USD
28 Apr 2017
Change (% chg)

$-0.25 (-0.40%)
Prev Close
$62.58
Open
$62.54
Day's High
$62.65
Day's Low
$62.15
Volume
3,041,992
Avg. Vol
3,099,644
52-wk High
$66.80
52-wk Low
$53.07

All Insider Trades
Trading Date Name Title Type Shares Traded Price
2 Feb 2017

Schechter (Adam H)

Officer Buy 26,135 $33.49
2 Feb 2017

Schechter (Adam H)

Officer Sell 36,335 $63.73
2 Feb 2017

Wendell (Peter C)

Director Sell 15,000 $63.69
2 Feb 2017

Wendell (Peter C)

Director Buy 5,000 $35.19
2 Feb 2017

Schechter (Adam H)

Officer Buy 10,200 $36.56
2 Feb 2017

Holston Michael J

General Counsel Sell 14,000 $63.69
9 Nov 2016

Frazier (Kenneth C)

Chief Executive Officer Sell 133,920 $65.03
9 Nov 2016

Frazier (Kenneth C)

Chief Executive Officer Buy 133,920 $23.45
8 Nov 2016

Frazier (Kenneth C)

Chief Executive Officer Sell 6,080 $65.00
8 Nov 2016

Frazier (Kenneth C)

Chief Executive Officer Buy 6,080 $23.45
6 Nov 2016

Gerberding (Julie L)

Officer Sell 85,523 $60.02
6 Nov 2016

Gerberding (Julie L)

Officer Buy 36,563 $39.29
6 Nov 2016

Gerberding (Julie L)

Officer Buy 38,647 $44.98
6 Nov 2016

Gerberding (Julie L)

Officer Buy 10,313 $36.56
1 Nov 2016

Lazarus (Rochelle B)

Director Buy 5,000 $24.30
1 Nov 2016

Lazarus (Rochelle B)

Director Sell 20,000 $59.06
1 Nov 2016

Lazarus (Rochelle B)

Director Buy 5,000 $35.19
1 Nov 2016

Lazarus (Rochelle B)

Director Buy 5,000 $51.86
1 Nov 2016

Wendell (Peter C)

Director Sell 5,000 $59.50
1 Nov 2016

Wendell (Peter C)

Director Buy 5,000 $51.86
1 Nov 2016

Lazarus (Rochelle B)

Director Buy 5,000 $38.04
2 Oct 2016

Graddick-Weir (Mirian M)

Officer Sell 40,800 $62.07
2 Oct 2016

Graddick-Weir (Mirian M)

Officer Buy 40,800 $44.19
31 Aug 2016

Schechter (Adam H)

Officer Sell 39,200 $62.61
31 Aug 2016

Schechter (Adam H)

Officer Buy 39,200 $33.49

Institutional Holders

% Shares Owned: 76.37%
# of Holders: 2,442
Total Shares Held: 2,093,679,144
3 Mo. Net Change: 3,296,758
# New Positions: 26
# Closed Positions: 9
# Increased Positions: 260
# Reduced Positions: 264
# Net Buyers: -4

Officers & Directors

Name Age Since Current Position

Kenneth Frazier

61 2011 Chairman of the Board, President, Chief Executive Officer

Robert Davis

50 2014 Chief Financial Officer, Executive Vice President

Clark Golestani

49 2012 Executive Vice President, Chief Information Officer

Michael Holston

53 2015 Executive Vice President, General Counsel

Mirian Graddick-Weir

61 2009 Executive Vice President - Human Resources

Sanat Chattopadhyay

2016 Executive Vice President and President - Merck Manufacturing Division

Richard DeLuca

53 2011 Executive Vice President, President - Merck Animal Health

Julie Gerberding

61 2015 Executive Vice President - Strategic Communications, Global Public Policy & Population Health

Roger Perlmutter

64 2013 Executive Vice President, President - Merck Research Laboratories

Michael Rosenblatt

68 2009 Executive Vice President, Chief Medical Officer

Adam Schechter

52 2010 Executive Vice President, President - Global Human Health

Rita Karachun

52 2014 Senior Vice President Finance - Global Controller

Adele Ambrose

59 2009 Senior Vice President, Chief Communications Officer

Leslie Brun

64 2016 Lead Independent Director

Thomas Cech

69 2009 Independent Director

Pamela Craig

60 2015 Independent Director

Thomas Glocer

57 2007 Independent Director

C. Robert Kidder

72 2005 Independent Director

Rochelle Lazarus

69 2004 Independent Director

Carlos Represas

72 2009 Independent Director

Paul Rothman

58 2015 Independent Director

Patricia Russo

64 1995 Independent Director

Craig Thompson

64 2008 Independent Director

Wendell Weeks

57 2004 Independent Director

Peter Wendell

65 2003 Independent Director

Joseph Romanelli

2015 IR Contact Officer